BCS Stock Analysis: Barclays | NYSE
Banks - Diversified | NYSE, USA | Market Cap: 78.976m USD | 12M Return: 15.2% | US06738E2046 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 116M
EPS Trend: 87.5%
Qual. Beats: 0
Rev. Trend: 75.9%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Barclays PLC is a global financial services provider headquartered in London, operating across the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. Founded in 1690, Barclays runs five core segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank and Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank. Its services span retail and wholesale banking, investment banking, wealth and investment management, mortgages, unsecured lending, credit cards, and securities dealing. The company trades on the NYSE under the ticker BCS as an ADR, reflecting its status as a UK-listed diversified bank accessible to U.S. investors.
As a large-cap diversified bank within the Financials sector, Barclays combines traditional retail and commercial banking with capital markets and wealth management activities. Its segment structure illustrates a universal banking model, balancing stable deposit and mortgage franchises in the UK with higher-risk, higher-return investment banking and U.S. consumer banking operations. The ADR structure allows U.S. investors to gain exposure to a UK-domiciled bank without trading directly on the London Stock Exchange, with pricing and dividends denominated in U.S. dollars.
- UK mortgage book repricing lifts net interest margins
- Investment banking fees rebound on debt capital markets activity
- US Consumer Bank credit card losses pressure segment profit
| Net Income: 7.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.81 > 1.0 |
| NWC/Revenue: -546.0% < 20% (prev -1.48k%; Δ 936.3% < -1%) |
| CFO/TA -0.00 > 3% & CFO -6.21b > Net Income 7.88b |
| Net Debt (-318b) to EBITDA (11.8b): -26.95 < 3 |
| Current Ratio: 0.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.43b) vs 12m ago -3.41% < -2% |
| Gross Margin: 45.58% > 18% (prev 92.11%; Δ -46.53% > 0.5%) |
| Asset Turnover: 2.39% > 50% (prev 1.72%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 0.46 > 6 (EBIT TTM 10.0b / Interest Expense TTM 21.7b) |
| A: -0.13 (Total Current Assets 456b - Total Current Liabilities 674b) / Total Assets 1730b |
| B: 0.03 (Retained Earnings 60.4b / Total Assets 1730b) |
| C: 0.01 (EBIT TTM 10.0b / Avg Total Assets 1665b) |
| D: 0.05 (Book Value of Equity 79.4b / Total Liabilities 1651b) |
| Altman-Z'' = -0.62 = B |
As of October 08, 2026, the stock is trading at USD 23.00 with a total of 8,881,518 shares traded. Over the past week, the price has changed by -5.23%, over one month by -14.18%, over three months by -15.15% and over the past year by +15.15%.
Current recommended Stop Loss: 22.20 (which is 3.5% or 1.5 ATR below the current price).
Barclays has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 29.9 | 30.1% |
Market Cap GBP = 59.8b (79.0b USD * 0.75689 USD.GBP)
P/E Trailing = 9.139
P/E Forward = 7.2359
P/S = 2.8064
P/B = 0.7861
P/EG = 0.9519
Revenue TTM = 39.9b GBP
EBIT TTM = 10.0b GBP
EBITDA TTM = 11.8b GBP
Long Term Debt = 76.7b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 73.1b GBP (from shortTermDebt, last fiscal year)
Debt = 138b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -318b GBP (calculated: Debt 138b - CCE 456b)
Enterprise Value = 59.8b GBP (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.46 (Ebit TTM 10.0b / Interest Expense TTM 21.7b)
EV/FCF = -7.41x (Enterprise Value 59.8b / FCF TTM -8.07b)
FCF Yield = -13.50% (FCF TTM -8.07b / Enterprise Value 59.8b)
FCF Margin = -20.25% (FCF TTM -8.07b / Revenue TTM 39.9b)
Net Margin = 19.76% (Net Income TTM 7.88b / Revenue TTM 39.9b)
Gross Margin = 45.58% ((Revenue TTM 39.9b - Cost of Revenue TTM 21.7b) / Revenue TTM)
Gross Margin QoQ = none% (prev 89.68%)
Tobins Q-Ratio = 0.03 (Enterprise Value 59.8b / Total Assets 1730b)
Interest Expense / Debt = 15.72% (Interest Expense 21.7b / Debt 138b)
Taxrate = 21.22% (2.13b / 10.0b)
NOPAT = 7.91b (EBIT 10.0b * (1 - 21.22%))
Current Ratio = 0.68 (Total Current Assets 456b / Total Current Liabilities 674b)
Debt / Equity = 1.74 (Debt 138b / totalStockholderEquity, last quarter 79.4b)
Debt / EBITDA = -26.95 (Net Debt -318b / EBITDA 11.8b)
Debt / FCF = 39.41 (negative FCF - burning cash) (Net Debt -318b / FCF TTM -8.07b)
Total Stockholder Equity = 77.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.88b / Total Assets 1730b)
RoE = 10.16% (Net Income TTM 7.88b / Total Stockholder Equity 77.6b)
RoCE = 6.51% (EBIT 10.0b / Capital Employed (Equity 77.6b + L.T.Debt 76.7b))
RoIC = 0.70% (NOPAT 7.91b / Invested Capital 1128b)
WACC = 11.67% (E(59.8b)/V(198b) * Re(10.01%) + D(138b)/V(198b) * Rd(15.72%) * (1-Tc(0.21)))
Discount Rate = 10.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -87.05 | Cagr: -3.82%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 87.46 | EPS CAGR: 17.85% | SUE: 0.21 | # QB: 0
Revenue Correlation: 75.94 | Revenue CAGR: 11.43% | SUE: 0.86 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.71 | Chg30d=+1.10% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.77 | Chg30d=-2.19% | Revisions=+0% | GrowthEPS=+15.0% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=3.30 | Chg30d=-1.00% | Revisions=-40% | GrowthEPS=+19.4% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: -12% (up=2, down=3)